Fetal surgery is not associated with increased inflammatory placental pathology

Prenat Diagn. 2023 Mar;43(3):382-392. doi: 10.1002/pd.6319. Epub 2023 Jan 30.

Abstract

Objective: Fetal surgery has improved neonatal outcomes; however, it is unknown if the intervention contributes to the developmental of inflammatory pathologies in the placenta. Here, an association between fetal surgery and placental pathology was examined.

Method: This case-control study compared pregnancies with fetal surgery (n = 22), pregnancies with an indication for fetal surgery but without an intervention being done (n = 13), and gestational-age and fetus-number matched controls (n = 36). Data on maternal, infant, and placental outcomes were abstracted. Additionally, immunohistochemistry identified expression of lymphoid and myeloid cells in the placenta on a subset of cases. Comparisons were performed using Kruskal-Wallis or Pearson's chi-squared tests.

Results: Maternal characteristics were comparable between groups. Most fetal interventions were for diaphragmatic hernia, spina bifida, or twin-to-twin transfusion syndrome. Fetuses who were operated on before birth were more likely to be born preterm (p = 0.02). There was no increase in the rate of observed placental pathologies or immune cell infiltration in fetal surgery cases compared to controls.

Conclusion: The data suggest that fetal surgery is not associated with increased inflammatory or morphologic pathology in the placenta. This observation supports the growing field of fetal surgery.

MeSH terms

  • Case-Control Studies
  • Female
  • Fetofetal Transfusion* / pathology
  • Fetus / surgery
  • Humans
  • Infant, Newborn
  • Parturition
  • Placenta* / pathology
  • Pregnancy